|
Almasy, L. (2003). Quantitative risk factors as indices of alcoholism susceptibility. Ann Med, 35(5), 337-343. Alongkronrusmee, D., Chiang, T., & van Rijn, R. M. (2016). Delta Opioid Pharmacology in Relation to Alcohol Behaviors. Handb Exp Pharmacol. doi:10.1007/164_2016_30 Ando, B., Rozsa, S., Kurgyis, E., Szkaliczki, A., Demeter, I., Szikszay, P., et al. (2014). Direct and indirect symptom severity indicators of alcohol dependence and the personality concept of the biosocial model. Subst Use Misuse, 49(4), 418-426. doi:10.3109/10826084.2013.841250 Anghelescu, I., Klawe, C., Singer, P., Fehr, C., Hiemke, C., Quante, A., et al. (2010). Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene. World J Biol Psychiatry, 11(2 Pt 2), 382-389. doi:10.1080/15622970701775058 Ashenhurst, J. R., Bujarski, S., & Ray, L. A. (2012). Delta and kappa opioid receptor polymorphisms influence the effects of naltrexone on subjective responses to alcohol. Pharmacol Biochem Behav, 103(2), 253-259. doi:10.1016/j.pbb.2012.08.019 Bali, A., Randhawa, P. K., & Jaggi, A. S. (2015). Stress and opioids: role of opioids in modulating stress-related behavior and effect of stress on morphine conditioned place preference. Neurosci Biobehav Rev, 51, 138-150. doi:10.1016/j.neubiorev.2014.12.018 Bart, G., Heilig, M., LaForge, K. S., Pollak, L., Leal, S. M., Ott, J., et al. (2004). Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry, 9(6), 547-549. doi:10.1038/sj.mp.4001504 Beer, B., Erb, R., Pavlic, M., Ulmer, H., Giacomuzzi, S., Riemer, Y., et al. (2013). Association of polymorphisms in pharmacogenetic candidate genes (OPRD1, GAL, ABCB1, OPRM1) with opioid dependence in European population: a case-control study. PLoS One, 8(9), e75359. doi:10.1371/journal.pone.0075359 Boileau, I., Assaad, J. M., Pihl, R. O., Benkelfat, C., Leyton, M., Diksic, M., et al. (2003). Alcohol promotes dopamine release in the human nucleus accumbens. Synapse, 49(4), 226-231. doi:10.1002/syn.10226 Brodie, M. S., Pesold, C., & Appel, S. B. (1999). Ethanol directly excites dopaminergic ventral tegmental area reward neurons. Alcohol Clin Exp Res, 23(11), 1848-1852. Chen, W. J., Chen, H. M., Chen, C. C., Yu, W. Y., & Cheng, A. T. (2002). Cloninger's Tridimensional Personality Questionnaire: psychometric properties and construct validity in Taiwanese adults. Compr Psychiatry, 43(2), 158-166. Chen, Y. C., Prescott, C. A., Walsh, D., Patterson, D. G., Riley, B. P., Kendler, K. S., et al. (2011). Different phenotypic and genotypic presentations in alcohol dependence: age at onset matters. J Stud Alcohol Drugs, 72(5), 752-762. Clarke, T. K., Crist, R. C., Kampman, K. M., Dackis, C. A., Pettinati, H. M., O'Brien, C. P., et al. (2013). Low frequency genetic variants in the mu-opioid receptor (OPRM1) affect risk for addiction to heroin and cocaine. Neurosci Lett, 542, 71-75. doi:10.1016/j.neulet.2013.02.018 Cloninger, C. R. (1987). A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry, 44(6), 573-588. Cloninger, C. R. (1995). The psychobiological regulation of social cooperation. Nat Med, 1(7), 623-625. Cloninger, C. R., Sigvardsson, S., & Bohman, M. (1996). Type I and Type II Alcoholism: An Update. Alcohol Health & Research World, 20(1), 18-23. Coller, J. K., Beardsley, J., Bignold, J., Li, Y., Merg, F., Sullivan, T., et al. (2009). Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. Pharmgenomics Pers Med, 2, 9-19. Crist, R. C., Ambrose-Lanci, L. M., Vaswani, M., Clarke, T. K., Zeng, A., Yuan, C., et al. (2013). Case-control association analysis of polymorphisms in the delta-opioid receptor, OPRD1, with cocaine and opioid addicted populations. Drug Alcohol Depend, 127(1-3), 122-128. doi:10.1016/j.drugalcdep.2012.06.023 Crist, R. C., Clarke, T. K., Ang, A., Ambrose-Lanci, L. M., Lohoff, F. W., Saxon, A. J., et al. (2013). An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology, 38(10), 2003-2010. doi:10.1038/npp.2013.99 Crum, R. M., Storr, C. L., & Chan, Y. F. (2005). Depression syndromes with risk of alcohol dependence in adulthood: a latent class analysis. Drug Alcohol Depend, 79(1), 71-81. doi:10.1016/j.drugalcdep.2005.01.001 Dobashi, I., Inada, T., & Hadano, K. (1997). Alcoholism and gene polymorphisms related to central dopaminergic transmission in the Japanese population. Psychiatr Genet, 7(2), 87-91. Dohrenwend, B. P., & Dohrenwend, B. S. (1974). Social and cultural influences on psychopathology. Annu Rev Psychol, 25, 417-452. doi:10.1146/annurev.ps.25.020174.002221 Endicott, J., & Spitzer, R. L. (1978). A diagnostic interview: the schedule for affective disorders and schizophrenia. Arch Gen Psychiatry, 35(7), 837-844. Eshleman, A. J., Henningsen, R. A., Neve, K. A., & Janowsky, A. (1994). Release of dopamine via the human transporter. Mol Pharmacol, 45(2), 312-316. Evren, C., Durkaya, M., Evren, B., Dalbudak, E., & Cetin, R. (2012). Relationship of relapse with impulsivity, novelty seeking and craving in male alcohol-dependent inpatients. Drug Alcohol Rev, 31(1), 81-90. doi:10.1111/j.1465-3362.2011.00303.x Fairbanks, L. A., Bailey, J. N., Breidenthal, S. E., Laudenslager, M. L., Kaplan, J. R., & Jorgensen, M. J. (2011). Environmental stress alters genetic regulation of novelty seeking in vervet monkeys. Genes Brain Behav, 10(6), 683-688. doi:10.1111/j.1601-183X.2011.00707.x Gao, X., Wang, Y., Lang, M., Yuan, L., Reece, A. S., & Wang, W. (2017). Contribution of Genetic Polymorphisms and Haplotypes in DRD2, BDNF, and Opioid Receptors to Heroin Dependence and Endophenotypes Among the Han Chinese. Omics, 21(7), 404-412. doi:10.1089/omi.2017.0057 Gelernter, J., Kranzler, H., & Cubells, J. (1999). Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects. Mol Psychiatry, 4(5), 476-483. Genro, J. P., Zeni, C., Polanczyk, G. V., Roman, T., Rohde, L. A., & Hutz, M. H. (2007). A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children. Am J Med Genet B Neuropsychiatr Genet, 144b(2), 215-219. doi:10.1002/ajmg.b.30428 Gerra, G., Leonardi, C., Cortese, E., D'Amore, A., Lucchini, A., Strepparola, G., et al. (2007). Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am J Med Genet B Neuropsychiatr Genet, 144B(6), 771-775. doi:10.1002/ajmg.b.30510 Gizer, I. R., Ficks, C., & Waldman, I. D. (2009). Candidate gene studies of ADHD: a meta-analytic review. Hum Genet, 126(1), 51-90. doi:10.1007/s00439-009-0694-x Glatt, S. J., Bousman, C., Wang, R. S., Murthy, K. K., Rana, B. K., Lasky-Su, J. A., et al. (2007). Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug Alcohol Depend, 90(2-3), 159-165. doi:10.1016/j.drugalcdep.2007.02.022 Goeders, N. E. (2003). The impact of stress on addiction. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology, 13(6), 435-441. Goldman, D., Oroszi, G., & Ducci, F. (2005). The genetics of addictions: uncovering the genes. Nat Rev Genet, 6(7), 521-532. doi:10.1038/nrg1635 Haeffel, G. J., Getchell, M., Koposov, R. A., Yrigollen, C. M., Deyoung, C. G., Klinteberg, B. A., et al. (2008). Association between polymorphisms in the dopamine transporter gene and depression: evidence for a gene-environment interaction in a sample of juvenile detainees. Psychol Sci, 19(1), 62-69. doi:10.1111/j.1467-9280.2008.02047.x Haerian, B. S., & Haerian, M. S. (2013). OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. Pharmacogenomics, 14(7), 813-824. doi:10.2217/pgs.13.57 Haile, C. N., Kosten, T. A., & Kosten, T. R. (2008). Pharmacogenetic treatments for drug addiction: alcohol and opiates. Am J Drug Alcohol Abuse, 34(4), 355-381. doi:10.1080/00952990802122564 Hancock, D. B., Levy, J. L., Gaddis, N. C., Glasheen, C., Saccone, N. L., Page, G. P., et al. (2015). Cis-Expression Quantitative Trait Loci Mapping Reveals Replicable Associations with Heroin Addiction in OPRM1. Biol Psychiatry, 78(7), 474-484. doi:10.1016/j.biopsych.2015.01.003 Hernandez, J., Segarra, A. B., Ramirez, M., Banegas, I., de Gasparo, M., Alba, F., et al. (2009). Stress influences brain enkephalinase, oxytocinase and angiotensinase activities: a new hypothesis. Neuropsychobiology, 59(3), 184-189. doi:10.1159/000219306 Holmes, T. H., & Rahe, R. H. (1967). The Social Readjustment Rating Scale. J Psychosom Res, 11(2), 213-218. Hong, C. J., Cheng, C. Y., Shu, L. R., Yang, C. Y., & Tsai, S. J. (2003). Association study of the dopamine and serotonin transporter genetic polymorphisms and methamphetamine abuse in Chinese males. J Neural Transm (Vienna), 110(4), 345-351. doi:10.1007/s00702-002-0790-8 Huang, C. C., Lu, R. B., Shih, M. C., Yen, C. H., & Huang, S. Y. (2011). Association study of the dopamine transporter gene with personality traits and major depressive disorder in the Han Chinese population. Pharmacogenet Genomics, 21(2), 94-97. doi:10.1097/FPC.0b013e3283424d94 Huang, C. C., Lu, R. B., Yen, C. H., Yeh, Y. W., Chou, H. W., Kuo, S. C., et al. (2015). Dopamine transporter gene may be associated with bipolar disorder and its personality traits. Eur Arch Psychiatry Clin Neurosci, 265(4), 281-290. doi:10.1007/s00406-014-0570-0 Huang, S. Y., Chen, H. K., Ma, K. H., Shy, M. J., Chen, J. H., Lin, W. C., et al. (2010). Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese. Schizophr Res, 116(1), 68-74. doi:10.1016/j.schres.2009.10.004 Huang, S. Y., Lin, W. W., Wan, F. J., Chang, A. J., Ko, H. C., Wang, T. J., et al. (2007). Monoamine oxidase-A polymorphisms might modify the association between the dopamine D2 receptor gene and alcohol dependence. J Psychiatry Neurosci, 32(3), 185-192. Isaza, C., Henao, J., Beltran, L., Porras, L., Gonzalez, M., Cruz, R., et al. (2013). Genetic variants associated with addictive behavior in Colombian addicted and non-addicted to heroin or cocaine. Colomb Med (Cali), 44(1), 19-25. Jiao, X., Pare, W. P., & Tejani-Butt, S. M. (2006). Alcohol consumption alters dopamine transporter sites in Wistar-Kyoto rat brain. Brain Res, 1073-1074, 175-182. doi:10.1016/j.brainres.2005.12.009 Kazantseva, A., Gaysina, D., Malykh, S., & Khusnutdinova, E. (2011). The role of dopamine transporter (SLC6A3) and dopamine D2 receptor/ankyrin repeat and kinase domain containing 1 (DRD2/ANKK1) gene polymorphisms in personality traits. Prog Neuropsychopharmacol Biol Psychiatry, 35(4), 1033-1040. doi:10.1016/j.pnpbp.2011.02.013 Kelada, S. N., Costa-Mallen, P., Checkoway, H., Carlson, C. S., Weller, T. S., Swanson, P. D., et al. (2005). Dopamine transporter (SLC6A3) 5' region haplotypes significantly affect transcriptional activity in vitro but are not associated with Parkinson's disease. Pharmacogenet Genomics, 15(9), 659-668. Kranzler, H. R., Armeli, S., Tennen, H., Covault, J., Feinn, R., Arias, A. J., et al. (2011). A double-blind, randomized trial of sertraline for alcohol dependence: moderation by age of onset [corrected] and 5-hydroxytryptamine transporter-linked promoter region genotype. J Clin Psychopharmacol, 31(1), 22-30. doi:10.1097/JCP.0b013e31820465fa Krebs, R. M., Heipertz, D., Schuetze, H., & Duzel, E. (2011). Novelty increases the mesolimbic functional connectivity of the substantia nigra/ventral tegmental area (SN/VTA) during reward anticipation: Evidence from high-resolution fMRI. Neuroimage, 58(2), 647-655. doi:10.1016/j.neuroimage.2011.06.038 Kreek, M. J., LaForge, K. S., & Butelman, E. (2002). Pharmacotherapy of addictions. Nat Rev Drug Discov, 1(9), 710-726. doi:10.1038/nrd897 Kumar, D., Chakraborty, J., & Das, S. (2012). Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population. Prog Neuropsychopharmacol Biol Psychiatry, 36(2), 225-230. doi:10.1016/j.pnpbp.2011.10.018 Kung, J. C., Chen, T. C., Shyu, B. C., Hsiao, S., & Huang, A. C. (2010). Anxiety- and depressive-like responses and c-fos activity in preproenkephalin knockout mice: oversensitivity hypothesis of enkephalin deficit-induced posttraumatic stress disorder. J Biomed Sci, 17, 29. doi:10.1186/1423-0127-17-29 Le Merrer, J., Becker, J. A., Befort, K., & Kieffer, B. L. (2009). Reward processing by the opioid system in the brain. Physiol Rev, 89(4), 1379-1412. doi:10.1152/physrev.00005.2009 Le Strat, Y., Ramoz, N., Pickering, P., Burger, V., Boni, C., Aubin, H. J., et al. (2008). The 3' part of the dopamine transporter gene DAT1/SLC6A3 is associated with withdrawal seizures in patients with alcohol dependence. Alcohol Clin Exp Res, 32(1), 27-35. doi:10.1111/j.1530-0277.2007.00552.x Leggio, L., Kenna, G. A., Fenton, M., Bonenfant, E., & Swift, R. M. (2009). Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev, 19(1), 115-129. doi:10.1007/s11065-008-9080-z Levran, O., Londono, D., O'Hara, K., Nielsen, D. A., Peles, E., Rotrosen, J., et al. (2008). Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav, 7(7), 720-729. doi:10.1111/j.1601-183X.2008.00410.x Levran, O., Peles, E., Randesi, M., Li, Y., Rotrosen, J., Ott, J., et al. (2014). Stress-related genes and heroin addiction: a role for a functional FKBP5 haplotype. Psychoneuroendocrinology, 45, 67-76. doi:10.1016/j.psyneuen.2014.03.017 Lind, P. A., Eriksson, C. J., & Wilhelmsen, K. C. (2009). Association between harmful alcohol consumption behavior and dopamine transporter (DAT1) gene polymorphisms in a male Finnish population. Psychiatr Genet, 19(3), 117-125. doi:10.1097/YPG.0b013e32832a4f7b Littlefield, A. K., & Sher, K. J. (2010). The Multiple, Distinct Ways that Personality Contributes to Alcohol Use Disorders. Soc Personal Psychol Compass, 4(9), 767-782. doi:10.1111/j.1751-9004.2010.00296.x Ma, Y., Fan, R., & Li, M. D. (2016). Meta-Analysis Reveals Significant Association of the 3'-UTR VNTR in SLC6A3 with Alcohol Dependence. Alcohol Clin Exp Res, 40(7), 1443-1453. doi:10.1111/acer.13104 Martinez, D., Gil, R., Slifstein, M., Hwang, D. R., Huang, Y., Perez, A., et al. (2005). Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry, 58(10), 779-786. doi:10.1016/j.biopsych.2005.04.044 Mayer, P., Rochlitz, H., Rauch, E., Rommelspacher, H., Hasse, H. E., Schmidt, S., et al. (1997). Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport, 8(11), 2547-2550. Meszaros, K., Lenzinger, E., Hornik, K., Fureder, T., Willinger, U., Fischer, G., et al. (1999). The Tridimensional Personality Questionnaire as a predictor of relapse in detoxified alcohol dependents. The European Fluvoxamine in Alcoholism Study Group. Alcohol Clin Exp Res, 23(3), 483-486. Mills, K. L., Lynskey, M., Teesson, M., Ross, J., & Darke, S. (2005). Post-traumatic stress disorder among people with heroin dependence in the Australian treatment outcome study (ATOS): prevalence and correlates. Drug Alcohol Depend, 77(3), 243-249. doi:10.1016/j.drugalcdep.2004.08.016 Mittleman, G., Call, S. B., Cockroft, J. L., Goldowitz, D., Matthews, D. B., & Blaha, C. D. (2011). Dopamine dynamics associated with, and resulting from, schedule-induced alcohol self-administration: analyses in dopamine transporter knockout mice. Alcohol, 45(4), 325-339. doi:10.1016/j.alcohol.2010.12.006 Muller, S. E., Weijers, H. G., Boning, J., & Wiesbeck, G. A. (2008). Personality traits predict treatment outcome in alcohol-dependent patients. Neuropsychobiology, 57(4), 159-164. doi:10.1159/000147469 Nedic Erjavec, G., Nenadic Sviglin, K., Nikolac Perkovic, M., Muck-Seler, D., Jovanovic, T., & Pivac, N. (2014). Association of gene polymorphisms encoding dopaminergic system components and platelet MAO-B activity with alcohol dependence and alcohol dependence-related phenotypes. Prog Neuropsychopharmacol Biol Psychiatry, 54, 321-327. doi:10.1016/j.pnpbp.2014.07.002 Nelson, E. C., Lynskey, M. T., Heath, A. C., Wray, N., Agrawal, A., Shand, F. L., et al. (2014). Association of OPRD1 polymorphisms with heroin dependence in a large case-control series. Addict Biol, 19(1), 111-121. doi:10.1111/j.1369-1600.2012.00445.x Nielsen, D. A., Ji, F., Yuferov, V., Ho, A., Chen, A., Levran, O., et al. (2008). Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Mol Psychiatry, 13(4), 417-428. doi:10.1038/sj.mp.4002147 Nikolov, M. A., Beltcheva, O., Galabova, A., Ljubenova, A., Jankova, E., Gergov, G., et al. (2011). No evidence of association between 118A>G OPRM1 polymorphism and heroin dependence in a large Bulgarian case-control sample. Drug Alcohol Depend, 117(1), 62-65. doi:10.1016/j.drugalcdep.2010.12.026 Norbeck, J. S. (1984). Modification of life event questionnaires for use with female respondents. Res Nurs Health, 7(1), 61-71. Nutt, D. J., King, L. A., & Phillips, L. D. (2010). Drug harms in the UK: a multicriteria decision analysis. Lancet, 376(9752), 1558-1565. doi:10.1016/s0140-6736(10)61462-6 Otter, C., Huber, J., & Bonner, A. (1995). Cloninger’s Tridimensonal Personality Questionnaire: Reliability in an English Sample. Person individ Diff, 18(4), 471-480. Pascale, E., Ferraguti, G., Codazzo, C., Passarelli, F., Mancinelli, R., Bonvicini, C., et al. (2015). Alcohol dependence and serotonin transporter functional polymorphisms 5-HTTLPR and rs25531 in an Italian population. Alcohol Alcohol, 50(3), 259-265. doi:10.1093/alcalc/agv014 Pettinati, H. M., Volpicelli, J. R., Kranzler, H. R., Luck, G., Rukstalis, M. R., & Cnaan, A. (2000). Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res, 24(7), 1041-1049. Rubie, C., Schmidt, F., Knapp, M., Sprandel, J., Wiegand, C., Meyer, J., et al. (2001). The human dopamine transporter gene: the 5'-flanking region reveals five diallelic polymorphic sites in a Caucasian population sample. Neurosci Lett, 297(2), 125-128. Sabol, S. Z., Nelson, M. L., Fisher, C., Gunzerath, L., Brody, C. L., Hu, S., et al. (1999). A genetic association for cigarette smoking behavior. Health Psychol, 18(1), 7-13. Sarason, I. G., Johnson, J. H., & Siegel, J. M. (1978). Assessing the impact of life changes: development of the Life Experiences Survey. J Consult Clin Psychol, 46(5), 932-946. Schmid, B., Blomeyer, D., Becker, K., Treutlein, J., Zimmermann, U. S., Buchmann, A. F., et al. (2009). The interaction between the dopamine transporter gene and age at onset in relation to tobacco and alcohol use among 19-year-olds. Addict Biol, 14(4), 489-499. doi:10.1111/j.1369-1600.2009.00171.x Schosser, A., Fuchs, K., Scharl, T., Schloegelhofer, M., Kindler, J., Mossaheb, N., et al. (2010). Interaction between serotonin 5-HT2A receptor gene and dopamine transporter (DAT1) gene polymorphisms influences personality trait of persistence in Austrian Caucasians. World J Biol Psychiatry, 11(2 Pt 2), 417-424. doi:10.3109/15622970801935586 Schwandt, M. L., Lindell, S. G., Higley, J. D., Suomi, S. J., Heilig, M., & Barr, C. S. (2011). OPRM1 gene variation influences hypothalamic-pituitary-adrenal axis function in response to a variety of stressors in rhesus macaques. Psychoneuroendocrinology, 36(9), 1303-1311. doi:10.1016/j.psyneuen.2011.03.002 Schwantes-An, T. H., Zhang, J., Chen, L. S., Hartz, S. M., Culverhouse, R. C., Chen, X., et al. (2016). Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. Behav Genet, 46(2), 151-169. doi:10.1007/s10519-015-9737-3 Sharafshah, A., Fazel, H., Albonaim, A., Omarmeli, V., Rezaei, S., Mirzajani, E., et al. (2017). Association of OPRD1 Gene Variants with Opioid Dependence in Addicted Male Individuals Undergoing Methadone Treatment in the North of Iran. J Psychoactive Drugs, 49(3), 242-251. doi:10.1080/02791072.2017.1290303 Shi, J., Hui, L., Xu, Y., Wang, F., Huang, W., & Hu, G. (2002). Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin. Hum Mutat, 19(4), 459-460. doi:10.1002/humu.9026 Shibuya, N., Kamata, M., Suzuki, A., Matsumoto, Y., Goto, K., & Otani, K. (2009). The -67 A/T promoter polymorphism in the dopamine transporter gene affects personality traits of Japanese healthy females. Behav Brain Res, 203(1), 23-26. doi:10.1016/j.bbr.2009.04.008 Sillivan, S. E., Whittard, J. D., Jacobs, M. M., Ren, Y., Mazloom, A. R., Caputi, F. F., et al. (2013). ELK1 transcription factor linked to dysregulated striatal mu opioid receptor signaling network and OPRM1 polymorphism in human heroin abusers. Biol Psychiatry, 74(7), 511-519. doi:10.1016/j.biopsych.2013.04.012 Slavich, G. M., Tartter, M. A., Brennan, P. A., & Hammen, C. (2014). Endogenous opioid system influences depressive reactions to socially painful targeted rejection life events. Psychoneuroendocrinology, 49, 141-149. doi:10.1016/j.psyneuen.2014.07.009 Smyth, B., Hoffman, V., Fan, J., & Hser, Y. I. (2007). Years of potential life lost among heroin addicts 33 years after treatment. Prev Med, 44(4), 369-374. doi:10.1016/j.ypmed.2006.10.003 Tan, A. T., Dular, R., & Innes, I. R. (1981). Alcohol feeding alters (3H)dopamine uptake into rat cortical and brain stem synaptosomes. Prog Biochem Pharmacol, 18, 224-230. Tan, E. C., Tan, C. H., Karupathivan, U., & Yap, E. P. (2003). Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport, 14(4), 569-572. doi:10.1097/01.wnr.0000061020.47393.fc Tzeng, N. S., Lu, R. B., Yeh, H. W., Yeh, Y. W., Huang, C. C., Yen, C. H., et al. (2015). The dopamine transporter gene may not contribute to susceptibility and the specific personality traits of amphetamine dependence. Drug Alcohol Depend, 149, 100-107. doi:10.1016/j.drugalcdep.2015.01.030 Ueno, S., Nakamura, M., Mikami, M., Kondoh, K., Ishiguro, H., Arinami, T., et al. (1999). Identification of a novel polymorphism of the human dopamine transporter (DAT1) gene and the significant association with alcoholism. Mol Psychiatry, 4(6), 552-557. Valentino, R. J., & Van Bockstaele, E. (2008). Convergent regulation of locus coeruleus activity as an adaptive response to stress. Eur J Pharmacol, 583(2-3), 194-203. doi:10.1016/j.ejphar.2007.11.062 van de Giessen, E., de Win, M. M., Tanck, M. W., van den Brink, W., Baas, F., & Booij, J. (2009). Striatal dopamine transporter availability associated with polymorphisms in the dopamine transporter gene SLC6A3. J Nucl Med, 50(1), 45-52. doi:10.2967/jnumed.108.053652 van der Zwaluw, C. S., Engels, R. C., Buitelaar, J., Verkes, R. J., Franke, B., & Scholte, R. H. (2009). Polymorphisms in the dopamine transporter gene (SLC6A3/DAT1) and alcohol dependence in humans: a systematic review. Pharmacogenomics, 10(5), 853-866. doi:10.2217/pgs.09.24 Van't Veer, A., & Carlezon, W. A., Jr. (2013). Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology (Berl), 229(3), 435-452. doi:10.1007/s00213-013-3195-5 Walter, M., Wiesbeck, G. A., Degen, B., Albrich, J., Oppel, M., Schulz, A., et al. (2011). Heroin reduces startle and cortisol response in opioid-maintained heroin-dependent patients. Addict Biol, 16(1), 145-151. doi:10.1111/j.1369-1600.2010.00205.x Wingo, T., Nesil, T., Choi, J. S., & Li, M. D. (2015). Novelty Seeking and Drug Addiction in Humans and Animals: From Behavior to Molecules. J Neuroimmune Pharmacol. doi:10.1007/s11481-015-9636-7 Woodcock, E. A., Lundahl, L. H., Burmeister, M., & Greenwald, M. K. (2015). Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study. Am J Addict, 24(4), 329-335. doi:10.1111/ajad.12187 Wu, X., Zhong, S., Gao, C., Bao, J., Hu, L., Ruan, Y., et al. (2009). Association Analysis of Dopamine D2 (DRD2), Dopamine D4 receptor (DRD4) and Dopamine transporter (DAT) Gene Polymorphisms with Alcohol Dependence. Prog Mod Biomed, 9, 1440-1442. Xu, K., Seo, D., Hodgkinson, C., Hu, Y., Goldman, D., & Sinha, R. (2013). A variant on the kappa opioid receptor gene (OPRK1) is associated with stress response and related drug craving, limbic brain activation and cocaine relapse risk. Transl Psychiatry, 3, e292. doi:10.1038/tp.2013.62 Xu, M., & Lin, Z. (2011). Genetic influences of dopamine transport gene on alcohol dependence: a pooled analysis of 13 studies with 2483 cases and 1753 controls. Prog Neuropsychopharmacol Biol Psychiatry, 35(5), 1255-1260. doi:10.1016/j.pnpbp.2010.11.001 Xuei, X., Flury-Wetherill, L., Bierut, L., Dick, D., Nurnberger, J., Jr., Foroud, T., et al. (2007). The opioid system in alcohol and drug dependence: family-based association study. Am J Med Genet B Neuropsychiatr Genet, 144B(7), 877-884. doi:10.1002/ajmg.b.30531 Yeh, Y. W., Lu, R. B., Tao, P. L., Shih, M. C., Lin, W. W., & Huang, S. Y. (2010). Neither single-marker nor haplotype analyses support an association between the dopamine transporter gene and heroin dependence in Han Chinese. Genes Brain Behav, 9(6), 638-647. doi:10.1111/j.1601-183X.2010.00597.x Ying, S. Y., & Lin, S. L. (2009). Intron-mediated RNA interference and microRNA biogenesis. Methods Mol Biol, 487, 387-413. doi:10.1007/978-1-60327-547-7_19 Yoshimoto, K., McBride, W. J., Lumeng, L., & Li, T. K. (1992). Alcohol stimulates the release of dopamine and serotonin in the nucleus accumbens. Alcohol, 9(1), 17-22. Yuferov, V., Fussell, D., LaForge, K. S., Nielsen, D. A., Gordon, D., Ho, A., et al. (2004). Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics, 14(12), 793-804. Zhang, A., Xing, Q., Wang, L., Du, J., Yu, L., Lin, Z., et al. (2007). Dopamine transporter polymorphisms and risperidone response in Chinese schizophrenia patients: an association study. Pharmacogenomics, 8(10), 1337-1345. doi:10.2217/14622416.8.10.1337 Zhang, H., Kranzler, H. R., Weiss, R. D., Luo, X., Brady, K. T., Anton, R. F., et al. (2009). Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies. Biol Psychiatry, 66(2), 128-136. doi:10.1016/j.biopsych.2008.12.021 Zhang, H., Kranzler, H. R., Yang, B. Z., Luo, X., & Gelernter, J. (2008). The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry, 13(5), 531-543. doi:10.1038/sj.mp.4002035
|